Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 552

    1.

    Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

    Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

    Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.

    Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH.

    Kidney Int. 2005 Jun;67(6):2325-9.PMID: 15882275 [PubMed - indexed for MEDLINE]Related articles

    3.

    Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.

    Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G.

    Diabetes Care. 2003 Sep;26(9):2632-6.PMID: 12941731 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy.

    Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R.

    Diabetes Care. 2004 May;27(5):1164-70.PMID: 15111539 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.

    Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, Rossing P, van Nieuwenhoven FA, Goldschmeding R.

    Diabetes Care. 2008 Jun;31(6):1177-82. Epub 2008 Mar 14.PMID: 18344285 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.

    Riser BL, Cortes P, DeNichilo M, Deshmukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D.

    Kidney Int. 2003 Aug;64(2):451-8.PMID: 12846740 [PubMed - indexed for MEDLINE]Related articles

    7.

    Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.

    Jaffa AA, Usinger WR, McHenry MB, Jaffa MA, Lipstiz SR, Lackland D, Lopes-Virella M, Luttrell LM, Wilson PW; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Group.

    J Clin Endocrinol Metab. 2008 May;93(5):1893-900. Epub 2008 Mar 4.PMID: 18319310 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.

    Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Höppener JW, Goldschmeding R.

    Am J Physiol Renal Physiol. 2006 Jun;290(6):F1344-54. Epub 2005 Dec 27.PMID: 16380465 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.

    Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, Twigg SM.

    J Diabetes Complications. 2008 Jul-Aug;22(4):284-94. Epub 2008 Apr 16.PMID: 18413184 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.

    Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM.

    Diabetologia. 2005 Dec;48(12):2650-60. Epub 2005 Nov 4.PMID: 16270194 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.

    Adler SG, Kang SW, Feld S, Cha DR, Barba L, Striker L, Striker G, Riser BL, LaPage J, Nast CC.

    Kidney Int. 2001 Dec;60(6):2330-6. Erratum in: Kidney Int 2002 Mar;61(3):1197. PMID: 11737607 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.

    Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A.

    Diabetes. 2000 Jul;49(7):1258-63.PMID: 10909986 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A novel accurate rapid ELISA for detection of urinary connective tissue growth factor, a biomarker of chronic allograft nephropathy.

    Bao J, Tu Z, Wang J, Ye F, Sun H, Qin M, Shi Y, Bu H, Li YP.

    Transplant Proc. 2008 Sep;40(7):2361-4.PMID: 18790235 [PubMed - indexed for MEDLINE]Related articles

    14.

    Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.

    Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH.

    Cytokine. 2009 Jul;47(1):37-42. Epub 2009 May 5.PMID: 19409809 [PubMed - indexed for MEDLINE]Related articles

    15.

    Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.

    Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HG, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CD, van Hinsbergh VW.

    Diabetes. 1999 Dec;48(12):2446-53.PMID: 10580435 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Increased collagen IV excretion in diabetes. A marker of compromised filtration function.

    Cohen MP, Lautenslager GT, Shearman CW.

    Diabetes Care. 2001 May;24(5):914-8.PMID: 11347754 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Serum adiponectin is increased in type 1 diabetic patients with nephropathy.

    Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane study group.

    Diabetes Care. 2005 Jun;28(6):1410-4.PMID: 15920060 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy.

    Mathiesen ER, Nexø E, Hommel E, Parving HH.

    Diabet Med. 1989 Mar;6(2):121-6.PMID: 2522852 [PubMed - indexed for MEDLINE]Related articles

    19.

    Proximal tubular reabsorption of growth hormone and sodium/fluid in normo- and microalbuminuric insulin-dependent diabetes mellitus.

    Turner G, Coates P, Warren S, Woodhead JS, Peters JR.

    Acta Diabetol. 1997 Mar;34(1):27-32.PMID: 9134054 [PubMed - indexed for MEDLINE]Related articles

    20.

    The predictive value of microalbuminuria in IDDM. A five-year follow-up study.

    Almdal T, Nörgaard K, Feldt-Rasmussen B, Deckert T.

    Diabetes Care. 1994 Feb;17(2):120-5.PMID: 8137681 [PubMed - indexed for MEDLINE]Related articles